Voloridge Investment Management, LLC Seres Therapeutics, Inc. Transaction History

Voloridge Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.62 $545,367 - $1.54 Million	-201,988 Reduced 48.13%	217,674 $747,000
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $77,004 - $108,051	-12,223 Reduced 2.83%	419,662 $2.99 Million
Q4 2021 Feb 14, 2022	SELL	$6.02 - $11.43 $2.27 Million - $4.31 Million	-377,496 Reduced 46.64%	431,885 $3.6 Million
Q3 2021 Nov 15, 2021	BUY	$5.46 - $22.6 $4.42 Million - $18.3 Million	809,381 New	809,381 $5.63 Million
Q4 2020 Feb 16, 2021	SELL	$23.25 - $37.73 $247,217 - $401,183	-10,633 Closed	0 $0

Q3 2020 Nov 16, 2020	BUY	$3.74 - $28.74 $39,767 - $305,592	10,633 New	10,633 $301,000

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.